Research overview

KLOW GHK-Cu, BPC-157, TB-500, KPV blend

KLOW is a four-peptide research blend of GHK-Cu, BPC-157, TB-500, and KPV, studied for copper-peptide, pentadecapeptide, thymosin-beta-4, and melanocortin-derived signaling pathways in research models.

Compound profile

Name: KLOW
Scientific name: GHK-Cu, BPC-157, TB-500, KPV blend
Category: Research peptide (research use only)
Documentation: Third-party tested; per-batch COA when available

Certificates of Analysis

Scientific literature

11 curated peer-reviewed studies and public references for KLOW. Each opens at its original source; provided for research reference only.

Pharmaceuticals (Basel) · 2025

Multifunctionality and Possible Medical Application of the BPC 157 Peptide-Literature and Patent Review

Frontiers in Pharmacology · 2024

PepT1-targeted nanodrug based on co-assembly of anti-inflammatory peptide and immunosuppressant for combined treatment of acute and chronic DSS-induced colitis

Archives of Medical Science · 2024

Thymosin beta4 improves the survival of cutaneous flaps of rats and activates the Wnt/beta-catenin pathway

Biomaterials Science · 2022

In situ mucoadhesive hydrogel capturing tripeptide KPV: the anti-inflammatory, antibacterial and repairing effect on chemotherapy-induced oral mucositis

Cardiovascular Therapeutics · 2022

Thymosin beta4 Protects against Cardiac Damage and Subsequent Cardiac Fibrosis in Mice with Myocardial Infarction

International Journal of Molecular Sciences · 2018

Regenerative and Protective Actions of the GHK-Cu Peptide in the Light of the New Gene Data

Current Pharmaceutical Design · 2018

BPC 157 and Standard Angiogenic Growth Factors. Gastrointestinal Tract Healing, Lessons from Tendon, Ligament, Muscle and Bone Healing

Molecular Therapy · 2017

Orally Targeted Delivery of Tripeptide KPV via Hyaluronic Acid-Functionalized Nanoparticles Efficiently Alleviates Ulcerative Colitis

Nature Scientific Reports · 2017

Global Proteomics-based Identification and Validation of Thymosin Beta-4 X-Linked as a Prognostic Marker for Head and Neck Squamous Cell Carcinoma

Gastroenterology · 2008

PepT1-Mediated Tripeptide KPV Uptake Reduces Intestinal Inflammation

Annals of the Rheumatic Diseases · 2007

alpha-MSH related peptides: a new class of anti-inflammatory and immunomodulating drugs

Literature last updated July 27, 2026

For Research Use Only

All products currently listed on this site are for research purposes only. Not for human or animal consumption. Intended strictly for qualified laboratories performing controlled in-vitro or analytical research. No medical, diagnostic, or therapeutic claims are made for any product. The references above are provided for research reference only and do not constitute claims about any product sold here.

KLOW — research grade, third-party tested

From $95.99. Tracked U.S. shipping — free on orders over $100.

Shop KLOW